277 related articles for article (PubMed ID: 38474168)
21. A comprehensive insight into the role of small nucleolar RNAs (snoRNAs) and SNHGs in human cancers.
Huldani H; Gandla K; Asiri M; Romero-Parra RM; Alsalamy A; Hjazi A; Najm MAA; Fawaz A; Hussien BM; Singh R
Pathol Res Pract; 2023 Sep; 249():154679. PubMed ID: 37567032
[TBL] [Abstract][Full Text] [Related]
22. FBL promotes cancer cell resistance to DNA damage and BRCA1 transcription via YBX1.
Sun X; Gao C; Xu X; Li M; Zhao X; Wang Y; Wang Y; Zhang S; Yan Z; Liu X; Wu C
EMBO Rep; 2023 Sep; 24(9):e56230. PubMed ID: 37489617
[TBL] [Abstract][Full Text] [Related]
23. A three-snoRNA signature: SNORD15A, SNORD35B and SNORD60 as novel biomarker for renal cell carcinoma.
Zhang Y; Shang X; Yu M; Bi Z; Wang K; Zhang Q; Xie L; Song X; Song X
Cancer Cell Int; 2023 Jul; 23(1):136. PubMed ID: 37443032
[TBL] [Abstract][Full Text] [Related]
24. Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019.
Siegel DA; King JB; Lupo PJ; Durbin EB; Tai E; Mills K; Van Dyne E; Buchanan Lunsford N; Henley SJ; Wilson RJ
J Natl Cancer Inst; 2023 Nov; 115(11):1337-1354. PubMed ID: 37433078
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms of snoRNA-IL-15 crosstalk in adipocyte lipolysis and NK cell rejuvenation.
Zhang Y; Zhao Z; Huang LA; Liu Y; Yao J; Sun C; Li Y; Zhang Z; Ye Y; Yuan F; Nguyen TK; Garlapati NR; Wu A; Egranov SD; Caudle AS; Sahin AA; Lim B; Beretta L; Calin GA; Yu D; Hung MC; Curran MA; Rezvani K; Gan B; Tan Z; Han L; Lin C; Yang L
Cell Metab; 2023 Aug; 35(8):1457-1473.e13. PubMed ID: 37329887
[TBL] [Abstract][Full Text] [Related]
26. SnoRNA and lncSNHG: Advances of nucleolar small RNA host gene transcripts in anti-tumor immunity.
Xiao H; Feng X; Liu M; Gong H; Zhou X
Front Immunol; 2023; 14():1143980. PubMed ID: 37006268
[TBL] [Abstract][Full Text] [Related]
27. The latest global burden of liver cancer: A past and present threat.
Oh JH; Jun DW
Clin Mol Hepatol; 2023 Apr; 29(2):355-357. PubMed ID: 36891606
[No Abstract] [Full Text] [Related]
28. Nucleolar URB1 ensures 3' ETS rRNA removal to prevent exosome surveillance.
Shan L; Xu G; Yao RW; Luan PF; Huang Y; Zhang PH; Pan YH; Zhang L; Gao X; Li Y; Cao SM; Gao SX; Yang ZH; Li S; Yang LZ; Wang Y; Wong CCL; Yu L; Li J; Yang L; Chen LL
Nature; 2023 Mar; 615(7952):526-534. PubMed ID: 36890225
[TBL] [Abstract][Full Text] [Related]
29. Global Switch from DICER-dependent MicroRNA to DICER-independent SnoRNA-derived RNA Biogenesis in Malignancy.
Godang NL; DeMeis JD; Houserova D; Chaudhary NY; Salter CJ; Xi Y; McDonald OG; Borchert GM
MicroPubl Biol; 2023; 2023():. PubMed ID: 36818311
[TBL] [Abstract][Full Text] [Related]
30. Identification of three small nucleolar RNAs (snoRNAs) as potential prognostic markers in diffuse large B-cell lymphoma.
Li MW; Huang FX; Xie ZC; Hong HY; Xu QY; Peng ZG
Cancer Med; 2023 Feb; 12(3):3812-3829. PubMed ID: 36812125
[TBL] [Abstract][Full Text] [Related]
31. Analysis of
Ariyanfar S; Good DJ
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672838
[TBL] [Abstract][Full Text] [Related]
32. Cancer statistics, 2023.
Siegel RL; Miller KD; Wagle NS; Jemal A
CA Cancer J Clin; 2023 Jan; 73(1):17-48. PubMed ID: 36633525
[TBL] [Abstract][Full Text] [Related]
33. TRPM8 promotes hepatocellular carcinoma progression by inducing SNORA55 mediated nuclear-mitochondrial communication.
Fu J; Liu G; Zhang X; Lei X; Liu Q; Qian K; Tong Q; Qin W; Li Z; Cao Z; Zhang J; Liu C; Wang Z; Liu Z; Liang XM; Yamamoto H; Xu X
Cancer Gene Ther; 2023 May; 30(5):738-751. PubMed ID: 36609627
[TBL] [Abstract][Full Text] [Related]
34. PQBP5/NOL10 maintains and anchors the nucleolus under physiological and osmotic stress conditions.
Jin X; Tanaka H; Jin M; Fujita K; Homma H; Inotsume M; Yong H; Umeda K; Kodera N; Ando T; Okazawa H
Nat Commun; 2023 Jan; 14(1):9. PubMed ID: 36599853
[TBL] [Abstract][Full Text] [Related]
35. Melanoma Treatments and Mortality Rate Trends in the US, 1975 to 2019.
Kahlon N; Doddi S; Yousif R; Najib S; Sheikh T; Abuhelwa Z; Burmeister C; Hamouda DM
JAMA Netw Open; 2022 Dec; 5(12):e2245269. PubMed ID: 36472871
[TBL] [Abstract][Full Text] [Related]
36. Global burden of primary liver cancer in 2020 and predictions to 2040.
Rumgay H; Arnold M; Ferlay J; Lesi O; Cabasag CJ; Vignat J; Laversanne M; McGlynn KA; Soerjomataram I
J Hepatol; 2022 Dec; 77(6):1598-1606. PubMed ID: 36208844
[TBL] [Abstract][Full Text] [Related]
37. Breast Cancer Statistics, 2022.
Giaquinto AN; Sung H; Miller KD; Kramer JL; Newman LA; Minihan A; Jemal A; Siegel RL
CA Cancer J Clin; 2022 Nov; 72(6):524-541. PubMed ID: 36190501
[TBL] [Abstract][Full Text] [Related]
38. Identification of key snoRNAs serves as biomarkers for hepatocellular carcinoma by bioinformatics methods.
Xie Q; Zhang D; Ye H; Wu Z; Sun Y; Shen H
Medicine (Baltimore); 2022 Sep; 101(39):e30813. PubMed ID: 36181013
[TBL] [Abstract][Full Text] [Related]
39. Ribosome-Directed Therapies in Cancer.
Temaj G; Chichiarelli S; Eufemi M; Altieri F; Hadziselimovic R; Farooqi AA; Yaylim I; Saso L
Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140189
[TBL] [Abstract][Full Text] [Related]
40. Antisense pairing and SNORD13 structure guide RNA cytidine acetylation.
Thalalla Gamage S; Bortolin-Cavaillé ML; Link C; Bryson K; Sas-Chen A; Schwartz S; Cavaillé J; Meier JL
RNA; 2022 Dec; 28(12):1582-1596. PubMed ID: 36127124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
